arrow_back Trending Legislation
Share share

Easier Access to Opioid Addiction Treatment via Medicaid

This act aims to simplify access to opioid addiction medications for individuals using the Medicaid program. Under the new rules, state Medicaid programs must provide at least one type of medication without prior authorization or dosage limits. This means quicker and simpler access to crucial treatment for many citizens.
Key points
Medicaid programs must cover at least one opioid addiction medication without prior approval.
No dosage limits will apply to these essential medications, making effective treatment easier.
The act also mandates a report to identify and assess other barriers to addiction treatment access.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
No Red Tape For Addiction Treatment Act
Print number: S 3522
Sponsor: Sen. Hassan, Margaret Wood [D-NH]
Process start date: 2025-12-17
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Easier Access to Opioid Addiction Treatment via Medicaid

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 3522.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-12-17.

What are the main provisions?

Key points include:

  • Medicaid programs must cover at least one opioid addiction medication without prior approval.
  • No dosage limits will apply to these essential medications, making effective treatment easier.
  • The act also mandates a report to identify and assess other barriers to addiction treatment access.

What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Hassan, Margaret Wood [D-NH].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-11.

Analysis and Potential Impact of S 3522

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health